Galmed develops heart-targeted nanoparticle formulation of Aramchol
Go back to Galmed develops heart-targeted nanoparticle formulation of Aramchol| GALMED PHARMACEUTIC (NASDAQ: GLMD) | Delayed: 0.55 +0.05 (10.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.50 | 52 Week High | $9.70 | |||
| Open | $0.48 | 52 Week Low | $2.78 | |||
| Day High | $0.56 | P/E | N/A | |||
| Day Low | $0.47 | EPS | $0.00 | |||
| Volume | 208,462 | |||||
